Insider filing · BGNE
Xiaobin Wu
President, COO & GM China
profile →
Xiaobin Wu sold $14.6M of BeiGene (BGNE)
Executed Apr 1 2025, disclosed Apr 3 2025, 2 days later.
Value, as filed
$14.6M
51,921 sh across 4 lots
Executed
Apr 1 2025
the trade date, as filed
Disclosed
Apr 3 2025
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
XWXiaobin Wu (President, COO & GM China) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in BeOne Medicines AG (ONC). The largest single filing was $5.6M of ONC (15,384 sh across 6 lots, as filed), executed Nov 12 2025.
The name
BGNE
BGNE
BGNE · 23 filings in 24 months
ticker →
Insider filings, newest first→
View the original filing at www.sec.gov→
Other filings by Xiaobin Wu in BGNE
BGNESALE
BeiGene, Ltd.
$13.5M51,721 sh across 3 lots
Exec Mar 5 2025
Filed Mar 7 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $12.5M
51,921 sh across 4 lots
Exec Feb 18 2025
Filed Feb 20 2025 · 5:30 PM ET BGNESALE BeiGene, Ltd. $1.0M
5,000 sh across 2 lots
Exec Sep 17 2024
Filed Sep 19 2024 · 5:30 PM ET